Drugs and Cosmetics Act: Schedules and Administration - Download PDF
Gain a clear understanding of the Drugs and Cosmetics Act, 1940, by exploring its comprehensive Schedules and the administrative framework responsible for its enforcement. Download our PDF, notes, and PPT to get a detailed list of the Schedules to the Act and Rules, and learn about the roles of various administrative bodies like CDSCO, State Drug Control Authorities, DTAB, and DCC.
This material is invaluable for pharmacy students, regulatory professionals, manufacturers, and anyone involved in the Indian pharmaceutical and cosmetic sectors. It simplifies the complex regulatory landscape. Download for offline access or view online.
Content Highlights:
- Comprehensive enlistment of the Schedules to the Drugs and Cosmetics Act and Rules, with brief explanations.
- Discussion on the administrative machinery: Central and State government roles, advisory bodies (DTAB, DCC), and executive bodies (CDSCO, State Licensing Authorities).
- Enforcement mechanisms and regulatory oversight.
Keywords:
Drugs and Cosmetics Act Schedules PDF, D&C Act Administration Notes, Pharmaceutical Regulation India PPT, CDSCO Role, State Drug Control, DTAB Functions, DCC India, Drug Law Enforcement, Download Free Notes, View Online DuloMix.
The Drugs and Cosmetics Act, 1940: Schedules and Administrative Framework
The Drugs and Cosmetics Act, 1940, and its accompanying Rules, 1945, are pivotal for regulating the quality, safety, and efficacy of drugs and cosmetics in India. This comprehensive legislation is structured through various schedules that detail specific requirements and is enforced by a well-defined administrative machinery at both Central and State levels.
Enlisting the Schedules to the Act and Rules
The Act itself contains two primary schedules, while the Drugs and Cosmetics Rules, 1945, contain numerous detailed schedules dictating various operational aspects. A foundational understanding of these is crucial.
Schedules to the Drugs and Cosmetics Act, 1940:
- The First Schedule: Lists authoritative books for Ayurvedic, Siddha, and Unani Tibb systems of medicine, defining the recognized traditional formulations.
- The Second Schedule: Specifies the standards to be complied with by imported drugs and by drugs manufactured for sale, sold, stocked, or exhibited for sale or distributed. It often refers to standards laid down in the Indian Pharmacopoeia (IP) and other recognized pharmacopoeias.
Key Schedules to the Drugs and Cosmetics Rules, 1945 (Illustrative List):
The Rules contain a wide array of schedules (from A to Y, and others like M1, M2, M3, H1 etc.), each addressing specific regulatory requirements. Some of the most significant include:
- Schedule A: Proforma for applications for licenses, issue and renewal of licenses, etc.
- Schedule C & C(1): Lists biological and other special products (e.g., vaccines, sera, certain antibiotics) that have stringent requirements for import, manufacture, sale, and distribution.
- Schedule D: Specifies information required for import licenses and lists drugs exempted from certain import provisions.
- Schedule E(1): Lists poisonous substances under Ayurvedic, Siddha, and Unani systems.
- Schedule F (and its parts like F-I, F-II, F-III, FF): Deals with standards for various specific product categories like blood banks (Part XIIB), bacterial and viral vaccines (F-I), surgical dressings (F-II), umbilical tapes (F-III), and ophthalmic preparations (FF).
- Schedule G: Drugs to be taken only under medical supervision. Carries a specific warning label.
- Schedule H: Prescription drugs, sold only against a prescription from a Registered Medical Practitioner. Schedule H1 includes drugs (certain antibiotics, habit-forming drugs) requiring stricter controls on sale and record-keeping.
- Schedule J: List of diseases and ailments for which drugs cannot claim to prevent or cure.
- Schedule K: Exempts certain classes of drugs from specific provisions relating to their manufacture or sale.
- Schedule M: Good Manufacturing Practices (GMP) for pharmaceuticals. Part M-I for Homoeopathic medicines, M-II for Cosmetics, M-III for Medical Devices. Crucial for quality assurance.
- Schedule N: Minimum equipment for a pharmacy.
- Schedule P & P1: Life period (expiry date) of drugs (P) and pack sizes of drugs (P1).
- Schedule Q: Permitted coal tar colors and pigments in cosmetics and soaps.
- Schedule R & R1: Standards for mechanical contraceptives like condoms (R) and medical devices (R1).
- Schedule S: Standards for cosmetics.
- Schedule T: Good Manufacturing Practices (GMP) for Ayurvedic, Siddha, and Unani medicines.
- Schedule U & U1: Particulars to be shown in manufacturing and analytical records for drugs (U) and cosmetics (U1).
- Schedule X: Narcotic and psychotropic substances requiring stringent controls on import, manufacture, sale, and record-keeping due to potential for abuse.
- Schedule Y: Requirements and guidelines for clinical trials for import and manufacture of new drugs.
This list is not exhaustive but highlights the breadth and depth of regulation covered by the Schedules, ensuring comprehensive control over pharmaceuticals and cosmetics.
Administration of the Act and Rules
The administration of the Drugs and Cosmetics Act and Rules is a collaborative effort involving both Central and State Governments, along with specific statutory bodies. The administrative structure can be broadly divided into advisory, analytical, and executive functions.
1. Advisory Bodies:
- Drugs Technical Advisory Board (DTAB): An advisory body constituted by the Central Government under Section 5 of the Act. Its primary role is to advise the Central Government and State Governments on technical matters arising out of the administration of this Act and to make rules. It comprises ex-officio members, nominated members (representing various interests like medical, pharmaceutical, and industry), and elected members. Its recommendations are crucial for amending the Act and Rules.
- Drugs Consultative Committee (DCC): Constituted by the Central Government under Section 7 of the Act. Its role is to advise the Central Government, State Governments, and the DTAB on any matter tending to secure uniformity throughout India in the administration of this Act. It consists of two representatives of the Central Government and one representative of each State Government.
2. Analytical Bodies (Laboratories):
- Central Drugs Laboratory (CDL), Kolkata: The statutory laboratory for testing drugs. It analyzes samples of drugs sent by customs collectors or courts. It also acts as an appellate laboratory. Certain other specialized institutions are also designated as CDLs for specific classes of drugs (e.g., Central Research Institute, Kasauli for biologicals; Indian Veterinary Research Institute, Izatnagar/Mukteswar for veterinary biologicals).
- State Drugs Control Laboratories: Established by State Governments for testing drug samples drawn by Drugs Inspectors within their respective states.
- Government Analysts: Appointed by Central and State Governments to test samples of drugs and cosmetics. They submit test reports which are crucial evidence in legal proceedings.
3. Executive Bodies (Enforcement):
- Central Drugs Standard Control Organization (CDSCO): Headed by the Drugs Controller General of India (DCGI), CDSCO is the national regulatory authority under the Ministry of Health & Family Welfare. Its key functions include:
- Approval of new drugs and clinical trials.
- Import control and registration.
- Licensing of certain categories of drugs like vaccines, r-DNA products, and some medical devices.
- Setting standards for drugs, cosmetics, diagnostics, and devices.
- Coordinating activities of State Drug Control Organizations.
- Overseeing the Drug Technical Advisory Board (DTAB) and Drug Consultative Committee (DCC).
- State Drug Control Authorities / Food and Drug Administrations (FDAs): Each state has its own Drug Control Organization, headed by a Drug Controller. Their primary responsibilities include:
- Licensing of drug/cosmetic manufacturing units and sales establishments (pharmacies, wholesalers).
- Inspection of manufacturing premises and sales outlets.
- Drawing samples for testing and analysis.
- Investigation of complaints and contraventions of the Act.
- Launching prosecutions against offenders.
- Ensuring compliance with various Schedules (e.g., GMP under Schedule M, sale conditions under Schedule H/X).
- Licensing Authorities: Appointed by Central and State governments for issuing licenses for the manufacture, sale, and distribution of drugs and cosmetics.
- Controlling Authorities: Senior officers who supervise the licensing authorities and Drugs Inspectors.
- Drugs Inspectors: Appointed by Central and State Governments under Section 21. They are the primary field officers responsible for enforcing the provisions of the Act and Rules. Their powers include inspection, taking samples, seizing stocks, and initiating legal action (discussed in more detail under their specific functions).
The effective administration of the Drugs and Cosmetics Act relies on the coordinated functioning of these advisory, analytical, and executive bodies to ensure that all drugs and cosmetics available to the public are safe, efficacious, and of standard quality, thereby safeguarding public health.
Info!
If you are the copyright owner of this document and want to report it, please visit the copyright infringement notice page to submit a report.
